| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.9 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |